Literature DB >> 12947390

DNA damage checkpoint control in cells exposed to ionizing radiation.

George Iliakis1, Ya Wang, Jun Guan, Huichen Wang.   

Abstract

Damage induced in the DNA after exposure of cells to ionizing radiation activates checkpoint pathways that inhibit progression of cells through the G1 and G2 phases and induce a transient delay in the progression through S phase. Checkpoints together with repair and apoptosis are integrated in a circuitry that determines the ultimate response of a cell to DNA damage. Checkpoint activation typically requires sensors and mediators of DNA damage, signal transducers and effectors. Here, we review the current state of knowledge regarding mechanisms of checkpoint activation and proteins involved in the different steps of the process. Emphasis is placed on the role of ATM and ATR, as well on CHK1 and CHK2 kinases in checkpoint response. The roles of downstream effectors, such as P53 and the CDC25 family of proteins, are also described, and connections between repair and checkpoint activation are attempted. The role of checkpoints in genomic stability and the potential of improving the treatment of cancer by DNA damage inducing agents through checkpoint abrogation are also briefly outlined.

Entities:  

Keywords:  Non-programmatic

Mesh:

Year:  2003        PMID: 12947390     DOI: 10.1038/sj.onc.1206682

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  125 in total

1.  The kinetochore protein Bub1 participates in the DNA damage response.

Authors:  Chunying Yang; Haibo Wang; Yiran Xu; Kathryn L Brinkman; Hiromichi Ishiyama; Stephen T C Wong; Bo Xu
Journal:  DNA Repair (Amst)       Date:  2011-11-09

2.  Transcription profile of DNA damage response genes at G₀ lymphocytes exposed to gamma radiation.

Authors:  Divyalakshmi Saini; Shridevi Shelke; A Mani Vannan; Sneh Toprani; Vinay Jain; Birajalaxmi Das; M Seshadri
Journal:  Mol Cell Biochem       Date:  2012-01-19       Impact factor: 3.396

3.  Computational modeling of signaling pathways mediating cell cycle checkpoint control and apoptotic responses to ionizing radiation-induced DNA damage.

Authors:  Yuchao Zhao; In Chio Lou; Rory B Conolly
Journal:  Dose Response       Date:  2011-10-25       Impact factor: 2.658

4.  Spatiotemporal stability of Cu-ATSM and FLT positron emission tomography distributions during radiation therapy.

Authors:  Tyler J Bradshaw; Stephen Yip; Ngoneh Jallow; Lisa J Forrest; Robert Jeraj
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-03-28       Impact factor: 7.038

5.  Inhibition of TFII-I-dependent cell cycle regulation by p53.

Authors:  Zana P Desgranges; Jinwoo Ahn; Maria B Lazebnik; Todd Ashworth; Caleb Lee; Richard C Pestell; Naomi Rosenberg; Carol Prives; Ananda L Roy
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

6.  E2F4 regulates a stable G2 arrest response to genotoxic stress in prostate carcinoma.

Authors:  M E Crosby; J Jacobberger; D Gupta; R M Macklis; A Almasan
Journal:  Oncogene       Date:  2006-10-09       Impact factor: 9.867

7.  Identification of primary transcriptional regulation of cell cycle-regulated genes upon DNA damage.

Authors:  Tong Zhou; Jeff Chou; Thomas E Mullen; Rani Elkon; Yingchun Zhou; Dennis A Simpson; Pierre R Bushel; Richard S Paules; Edward K Lobenhofer; Patrick Hurban; William K Kaufmann
Journal:  Cell Cycle       Date:  2007-04-19       Impact factor: 4.534

8.  Increasing cisplatin sensitivity by schedule-dependent inhibition of AKT and Chk1.

Authors:  Lei Duan; Ricardo E Perez; Michael Hansen; Steven Gitelis; Carl G Maki
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

9.  Kinetics of CHO A L mutant expression after treatment with gamma radiation, EMS, and asbestos.

Authors:  Stephen B Keysar; Michael H Fox
Journal:  Cytometry A       Date:  2009-05       Impact factor: 4.355

10.  A histone deacetylase inhibitor, trichostatin A, enhances radiosensitivity by abrogating G2/M arrest in human carcinoma cells.

Authors:  In Ah Kim; Jin Ho Kim; Jin Hee Shin; Il Han Kim; Jae Sung Kim; Hong-Gyun Wu; Eui Kyu Chie; Yong Ho Kim; Bo-Kyung Kim; Semie Hong; Seok Won Park; Sung Whan Ha; Charn Il Park
Journal:  Cancer Res Treat       Date:  2005-04-30       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.